Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY9W6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,978
Award facts
- Contract value 100% obligated
- $20,977.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors, with a ceiling value of $20,977.63. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award utilized no set-aside designation, indicating competitive award to this qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. Through its comprehensive DLA contract vehicle, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. This delivery order for Dupixent, a biologic immunosuppressant used in the treatment of atopic dermatitis and other inflammatory conditions, exemplifies the company's role in supplying specialized pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FY9W6?
SPE2DR26FY9W6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FY9W6 worth?
The government has obligated $20,978 on SPE2DR26FY9W6.
Is contract SPE2DR26FY9W6 an order under another contract?
Yes. SPE2DR26FY9W6 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FY9W6 competed?
The extent of competition for SPE2DR26FY9W6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award